Northern Trust Corp Ginkgo Bioworks Holdings, Inc. Transaction History

Northern Trust Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.28 - $1.16 $16,611 - $68,820	-59,328 Reduced 0.99%	5,907,267 $1.95 Million
Q1 2024 May 14, 2024	SELL	$1.06 - $1.67 $189,841 - $299,090	-179,096 Reduced 2.91%	5,966,595 $6.92 Million
Q4 2023 Feb 13, 2024	BUY	$1.26 - $1.79 $246,592 - $350,317	195,708 Added 3.29%	6,145,691 $10.4 Million
Q3 2023 Nov 13, 2023	BUY	$1.61 - $2.54 $947,668 - $1.5 Million	588,614 Added 10.98%	5,949,983 $10.8 Million
Q2 2023 Aug 11, 2023	BUY	$1.14 - $1.95 $1.08 Million - $1.85 Million	949,129 Added 21.51%	5,361,369 $9.97 Million
Q1 2023 May 15, 2023	BUY	$1.2 - $2.19 $377,655 - $689,221	314,713 Added 7.68%	4,412,240 $5.87 Million
Q4 2022 Feb 13, 2023	BUY	$1.63 - $3.52 $1.64 Million - $3.53 Million	1,003,543 Added 32.44%	4,097,527 $6.92 Million
Q3 2022 Nov 14, 2022	SELL	$0.73 - $3.74 $170,262 - $872,302	-233,236 Reduced 7.01%	3,093,984 $9.65 Million
Q2 2022 Aug 12, 2022	BUY	$2.2 - $4.2 $2.93 Million - $5.59 Million	1,330,277 Added 66.62%	3,327,220 $7.92 Million
Q1 2022 May 13, 2022	SELL	$2.83 - $8.69 $155,151 - $476,420	-54,824 Reduced 2.67%	1,996,943 $8.05 Million
Q4 2021 Feb 08, 2022	BUY	$8.31 - $14.92 $17.1 Million - $30.6 Million	2,051,767 New	2,051,767 $17.1 Million

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $12.1B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.